Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Ndra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Ndra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ndra Today - Breaking & Trending Today

ENDRA Life Sciences (NDRA) Set to Announce Quarterly Earnings on Monday - Vimarsana News

ENDRA Life Sciences (NDRA) Set to Announce Quarterly Earnings on Monday

ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) will issue its quarterly earnings data after the market closes on Monday, May 15th. Analysts expect the company to announce earnings of ($1.02) per share for the quarter. ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) last issued its quarterly earnings results on Tuesday, March 14th. The company reported […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Director Acquires $99,999.60 in Stock - Vimarsana News

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Director Acquires $99,999.60 in Stock

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) Director Anthony Digiandomenico bought 83,333 shares of the firm’s stock in a transaction that occurred on Tuesday, May 2nd. The stock was bought at an average price of $1.20 per share, with a total value of $99,999.60. Following the transaction, the director now directly owns 102,434 shares […]

Insider Buying: ENDRA Life Sciences Inc. (NASDAQ:NDRA) Director Acquires 83,333 Shares of Stock - Vimarsana News

Insider Buying: ENDRA Life Sciences Inc. (NASDAQ:NDRA) Director Acquires 83,333 Shares of Stock

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) Director Anthony Digiandomenico acquired 83,333 shares of the company’s stock in a transaction dated Tuesday, May 2nd. The shares were bought at an average price of $1.20 per share, for a total transaction of $99,999.60. Following the purchase, the director now owns 102,434 shares in the company, […]

Source: wkrb13.com
ENDRA Life Sciences' (NDRA) "Buy" Rating Reaffirmed at HC Wainwright - Vimarsana News

ENDRA Life Sciences' (NDRA) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) in a report released on Friday morning, Benzinga reports. They currently have a $9.00 price objective on the stock. HC Wainwright also issued estimates for ENDRA Life Sciences’ Q1 2023 earnings at ($1.02) EPS, Q2 2023 earnings at ($0.70) […]

Zacks: Analysts Expect ENDRA Life Sciences Inc. (NASDAQ:NDRA) Will Post Earnings of -$0.05 Per Share - Vimarsana News

Zacks: Analysts Expect ENDRA Life Sciences Inc. (NASDAQ:NDRA) Will Post Earnings of -$0.05 Per Share

Equities analysts predict that ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) will announce earnings per share (EPS) of ($0.05) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for ENDRA Life Sciences’ earnings. ENDRA Life Sciences reported earnings of ($0.08) per share in the same quarter last year, which […]